|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bansal N, Yendluri V and Wenham RM: The
molecular biology of endometrial cancers and the implications for
pathogenesis, classification, and targeted therapies. Cancer Contr.
16:8–13. 2009. View Article : Google Scholar
|
|
4
|
Sherman ME and Devesa SS: Analysis of
racial differences in incidence, survival, and mortality for
malignant tumors of the uterine corpus. Cancer. 98:176–186. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hardiman P, Pillay OC and Atiomo W:
Polycystic ovary syndrome and endometrial carcinoma. Lancet.
361:1810–1812. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schouten LJ, Goldbohm RA and van den
Brandt PA: Anthropometry, physical activity, and endometrial cancer
risk: Results from the Netherlands cohort study. J Natl Cancer
Inst. 96:1635–1638. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kjaer SK, Mellemkjaer L, Brinton LA,
Johansen C, Gridley G and Olsen JH: Tubal sterilization and risk of
ovarian, endometrial and cervical cancer. A Danish population-based
follow-up study of more than 65 000 sterilized women. Int J
Epidemiol. 33:596–602. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Troisi R, Potischman N, Hoover RN, Siiteri
P and Brinton LA: Insulin and endometrial cancer. Am J Epidemiol.
146:476–482. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong TT, Wang YL and Ma XX: Age at
menarche and endome-trial cancer risk: A dose-response
meta-analysis of prospective studies. Sci Rep. 5:140512015.
View Article : Google Scholar
|
|
10
|
Fisher B, Costantino JP, Redmond CK,
Fisher ER, Wickerham DL and Cronin WM: Endometrial cancer in
tamoxifen-treated breast cancer patients: Findings from the
National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J
Natl Cancer Inst. 86:527–537. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ali AT: Reproductive factors and the risk
of endometrial cancer. Int J Gynecol Cancer. 24:384–393. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kurman RJ and Norris HJ: Evaluation of
criteria for distinguishing atypical endometrial hyperplasia from
well-differentiated carcinoma. Cancer. 49:2547–2559. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Felix AS, Weissfeld JL, Stone RA, Bowser
R, Chivukula M, Edwards RP and Linkov F: Factors associated with
type I and type II endometrial cancer. Cancer Causes Control.
21:1851–1856. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prat J: Prognostic parameters of
endometrial carcinoma. Hum Pathol. 35:649–662. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bendifallah S, Daraï E and Ballester M:
Predictive modeling: A new paradigm for managing endometrial
cancer. Ann Surg Oncol. 23:975–988. 2016. View Article : Google Scholar
|
|
17
|
McConechy MK, Ding J, Cheang MC, Wiegand
K, Senz J, Tone A, Yang W, Prentice L, Tse K, Zeng T, et al: Use of
mutation profiles to refine the classification of endometrial
carcinomas. J Pathol. 228:20–30. 2012.PubMed/NCBI
|
|
18
|
Talhouk A and McAlpine JN: New
classification of endometrial cancers: The development and
potential applications of genomic-based classification in research
and clinical care. Gynecol Oncol Res Pract. 3:142016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karateke A, Tug N, Cam C, Selcuk S, Asoglu
MR and Cakir S: Discrepancy of pre- and postoperative grades of
patients with endometrial carcinoma. Eur J Gynaecol Oncol.
32:283–285. 2011.PubMed/NCBI
|
|
20
|
Sany O, Singh K and Jha S: Correlation
between preoperative endometrial sampling and final endometrial
cancer histology. Eur J Gynaecol Oncol. 33:142–144. 2012.PubMed/NCBI
|
|
21
|
Batista TP, Cavalcanti CL, Tejo AA and
Bezerra AL: Accuracy of preoperative endometrial sampling diagnosis
for predicting the final pathology grading in uterine endometrioid
carcinoma. Eur J Surg Oncol. 42:1367–1371. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han G, Sidhu D, Duggan MA, Arseneau J,
Cesari M, Clement PB, Ewanowich CA, Kalloger SE and Köbel M:
Reproducibility of histological cell type in high-grade endometrial
carcinoma. Mod Pathol. 26:1594–1604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Banno K, Nogami Y, Kisu I, Yanokura M,
Umene K, Masuda K, Kobayashi Y, Yamagami W, Susumu N and Aoki D:
Candidate biomarkers for genetic and clinicopathological diagnosis
of endometrial cancer. Int J Mol Sci. 14:12123–12137. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stampoliou A, Arapantoni-Dadioti P and
Pavlakis K: Epigenetic mechanisms in endometrial cancer. J BUON.
21:301–306. 2016.PubMed/NCBI
|
|
25
|
Banno K, Yanokura M, Iida M, Masuda K and
Aoki D: Carcinogenic mechanisms of endometrial cancer: Involvement
of genetics and epigenetics. J Obstet Gynaecol Res. 40:1957–1967.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Banno K, Yanokura M, Susumu N, Kawaguchi
M, Hirao N, Hirasawa A, Tsukazaki K and Aoki D: Relationship of the
aberrant DNA hypermethylation of cancer-related genes with
carcinogenesis of endometrial cancer. Oncol Rep. 16:1189–1196.
2006.PubMed/NCBI
|
|
27
|
Guida M, Sanguedolce F, Bufo P, Di Spiezio
Sardo A, Bifulco G, Nappi C and Pannone G: Aberrant DNA
hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign,
premalignant and malignant endometrial lesions. Eur J Gynaecol
Oncol. 30:267–270. 2009.PubMed/NCBI
|
|
28
|
Sasaki M, Kotcherguina L, Dharia A,
Fujimoto S and Dahiya R: Cytosine-phosphoguanine methylation of
estrogen receptors in endometrial cancer. Cancer Res. 61:3262–3266.
2001.PubMed/NCBI
|
|
29
|
Ren Y, Liu X, Ma D, Feng Y and Zhong N:
Down-regulation of the progesterone receptor by the methylation of
progesterone receptor gene in endometrial cancer cells. Cancer
Genet Cytogenet. 175:107–116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Salvesen HB, Stefansson I, Kretzschmar EI,
Gruber P, MacDonald ND, Ryan A, Jacobs IJ, Akslen LA and Das S:
Significance of PTEN alterations in endometrial carcinoma: A
population-based study of mutations, promoter methylation and PTEN
protein expression. Int J Oncol. 25:1615–1623. 2004.PubMed/NCBI
|
|
31
|
Arafa M, Kridelka F, Mathias V,
Vanbellinghen JF, Renard I, Foidart JM, Boniver J and Delvenne P:
High frequency of RASSF1A and RARb2 gene promoter methylation in
morphologically normal endometrium adjacent to endometrioid
adenocarcinoma. Histopathology. 53:525–532. 2008.PubMed/NCBI
|
|
32
|
Esteller M, Hamilton SR, Burger PC, Baylin
SB and Herman JG: Inactivation of the DNA repair gene
O6-methylguanine-DNA methyltransferase by promoter hypermethylation
is a common event in primary human neoplasia. Cancer Res.
59:793–797. 1999.PubMed/NCBI
|
|
33
|
Ignatov A, Bischoff J, Ignatov T,
Schwarzenau C, Krebs T, Kuester D, Costa SD, Roessner A, Semczuk A
and Schneider-Stock R: APC promoter hypermethylation is an early
event in endometrial tumorigenesis. Cancer Sci. 101:321–327. 2010.
View Article : Google Scholar
|
|
34
|
Moreno-Bueno G, Hardisson D, Sánchez C,
Sarrió D, Cassia R, García-Rostán G, Prat J, Guo M, Herman JG,
Matías-Guiu X, et al: Abnormalities of the APC/beta-catenin pathway
in endometrial cancer. Oncogene. 21:7981–7990. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghaleb AM and Yang VW: Krüppel-like factor
4 (KLF4): What we currently know. Gene. 611:27–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
El-Karim EA, Hagos EG, Ghaleb AM, Yu B and
Yang VW: Krüppel-like factor 4 regulates genetic stability in mouse
embryonic fibroblasts. Mol Cancer. 12:892013. View Article : Google Scholar
|
|
37
|
Hagos EG, Ghaleb AM, Dalton WB, Bialkowska
AB and Yang VW: Mouse embryonic fibroblasts null for the
Krüppel-like factor 4 gene are genetically unstable. Oncogene.
28:1197–1205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoon HS, Chen X and Yang VW: Kruppel-like
factor 4 mediates p53-dependent G1/S cell cycle arrest in response
to DNA damage. J Biol Chem. 278:2101–2105. 2003. View Article : Google Scholar
|
|
39
|
Yang Y, Goldstein BG, Chao HH and Katz JP:
KLF4 and KLF5 regulate proliferation, apoptosis and invasion in
esophageal cancer cells. Cancer Biol Ther. 4:1216–1221. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zammarchi F, Morelli M, Menicagli M, Di
Cristofano C, Zavaglia K, Paolucci A, Campani D, Aretini P, Boggi
U, Mosca F, et al: KLF4 is a novel candidate tumor suppressor gene
in pancreatic ductal carcinoma. Am J Pathol. 178:361–372. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu T, Chen X, Zhang W, Liu J, Avdiushko R,
Napier DL, Liu AX, Neltner JM, Wang C, Cohen D and Liu C: KLF4
regulates adult lung tumor-initiating cells and represses
K-Rasmediated lung cancer. Cell Death Differ. 23:207–215. 2016.
View Article : Google Scholar
|
|
42
|
Ray SK: The transcription regulator
Krüppel-like factor 4 and its dual roles of oncogene in
glioblastoma and tumor suppressor in neuroblastoma. For
Immunopathol Dis Therap. 7:127–139. 2016. View Article : Google Scholar
|
|
43
|
Wei D, Gong W, Kanai M, Schlunk C, Wang L,
Yao JC, Wu TT, Huang S and Xie K: Drastic down-regulation of
Krüppel-like factor 4 expression is critical in human gastric
cancer development and progression. Cancer Res. 65:2746–2754. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vijaya Kumar A, Salem Gassar E, Spillmann
D, Stock C, Sen YP, Zhang T, Van Kuppevelt TH, Hülsewig C,
Koszlowski EO, Pavao MS, et al: HS3ST2 modulates breast cancer cell
invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation
of protease and cadherin expression. Int J Cancer. 135:2579–2592.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Suhovskih AV, Domanitskaya NV, Tsidulko
AY, Prudnikova TY, Kashuba VI and Grigorieva EV: Tissue-specificity
of heparan sulfate biosynthetic machinery in cancer. Cell Adhes
Migr. 9:452–459. 2015. View Article : Google Scholar
|
|
46
|
Nikolova V, Koo CY, Ibrahim SA, Wang Z,
Spillmann D, Dreier R, Kelsch R, Fischgräbe J, Smollich M, Rossi
LH, et al: Differential roles for membrane-bound and soluble
syndecan-1 (CD138) in breast cancer progression. Carcinogenesis.
30:397–407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Eklund A: Bee swarm: The Bee Swarm plot,
an alternative to stripchart. R package version 0.2.3. 2016,
https://CRAN.R-project.org/package=beeswarm.
|
|
48
|
Mair P and Schoenbrodt F: WRS2: Wilcox
robust estimation and testing. R package version 0.9.2. 2017.
|
|
49
|
Brigliadori G, Foca F, Dall’Agata M,
Rengucci C, Melegari E, Cerasoli S, Amadori D, Calistri D and Faedi
M: Defining the cutoff value of MGMT gene promoter methylation and
its predictive capacity in glioblastoma. J Neurooncol. 128:333–339.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gurrieri L, De Carlo E, Gerratana L, De
Maglio G, Macerelli M, Pisa FE, Masiero E, Aprile G, Follador A,
Puglisi F, et al: MGMT pyrosequencing-based cut-off methylation
level and clinical outcome in patients with glioblastoma
multiforme. Future Oncol. 14:699–707. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ishwaran H, Kogalur UB, Blackstone EH and
Lauer MS: Random survival forests. Ann Appl Stat. 2:841–860. 2008.
View Article : Google Scholar
|
|
52
|
R Development Core Team: R: A language and
environment for statistical computing. The R Foundation for
Statistical Computing; Vienna: http://www.R-project.org,
Accessed February 10, 2015.
|
|
53
|
Takeda T, Banno K, Yanokura M, Adachi M,
Iijima M, Kunitomi H, Nakamura K, Iida M, Nogami Y, Umene K, et al:
Methylation analysis of DNA mismatch repair genes using DNA derived
from the peripheral blood of patients with endometrial cancer:
Epimutation in endometrial carcinogenesis. Genes (Basel). 7. pp.
E862016, View Article : Google Scholar
|
|
54
|
Jiang SW, Li J, Podratz K and Dowdy S:
Application of DNA methylation biomarkers for endometrial cancer
management. Expert Rev Mol Diagn. 8:607–616. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chang CC, Wang HC, Liao YP, Chen YC, Weng
YC, Yu MH and Lai HC: The feasibility of detecting endometrial and
ovarian cancer using DNA methylation biomarkers in cervical
scrapings. J Gynecol Oncol. 29:e172018. View Article : Google Scholar
|
|
56
|
Lai HC, Wang YC, Yu MH, Huang RL, Yuan CC,
Chen KJ, Wu CC, Chiang KJ and Chao TK: DNA methylation as a
biomarker for the detection of hidden carcinoma in endometrial
atypical hyperplasia. Gynecol Oncol. 135:552–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wentzensen N, Bakkum-Gamez JN, Killian JK,
Sampson J, Guido R, Glass A, Adams L, Luhn P, Brinton LA, Rush B,
et al: Discovery and validation of methylation markers for
endometrial cancer. Int J Cancer. 135:1860–1868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang B, Xing X, Li J, Lowdon RF, Zhou Y,
Lin N, Zhang B, Sundaram V, Chiappinelli KB, Hagemann IS, et al:
Comparative DNA methylome analysis of endometrial carcinoma reveals
complex and distinct deregulation of cancer promoters and
enhancers. BMC Genomics. 15:8682014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen YC, Tsao CM, Kuo CC, Yu MH, Lin YW,
Yang CY, Li HJ, Yan MD, Wang TJ, Chou YC and Su HY: Quantitative
DNA methylation analysis of selected genes in endometrial
carcinogenesis. Taiwan J Obstet Gynecol. 54:572–579. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Trimble CL, Method M, Leitao M, Lu K,
Ioffe O, Hampton M, Higgins R, Zaino R and Mutter GL; Society of
Gynecologic Oncology Clinical Practice Committee: Management of
endo-metrial precancers. Obstet Gynecol. 120:1160–1175.
2012.PubMed/NCBI
|
|
61
|
Nieminen TT, Gylling A, Abdel-Rahman WM,
Nuorva K, Aarnio M, Renkonen-Sinisalo L, Järvinen HJ, Mecklin JP,
Bützow R and Peltomäki P: Molecular analysis of endometrial
tumorigenesis: Importance of complex hyperplasia regardless of
atypia. Clin Cancer Res. 15:5772–5783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yuan XL, Zhang Z, Li B, Gao N, Zhang H,
Sangild PT and Li JQ: Genome-wide DNA methylation analysis of the
porcine hypothalamus-pituitary-ovary axis. Sci Rep. 7:42772017.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Siegel EM, Riggs BM, Delmas AL, Koch A,
Hakam A and Brown KD: Quantitative DNA methylation analysis of
candidate genes in cervical cancer. PLoS One. 10:e01224952015.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Dvorakova E, Chmelarova M, Laco J, Palicka
V and Spacek J: Methylation analysis of tumor suppressor genes in
endometroid carcinoma of endometrium using MS-MLPA. Biomed Pap Med
Fac Univ Palacky Olomouc Czech Repub. 157:298–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Dong X, Hou Q, Chen Y and Wang X:
Diagnostic value of the methylation of multiple gene promoters in
serum in hepatitis B virus-related hepatocellular carcinoma. Dis
Markers. 2017.2929381:2017.
|
|
66
|
Boers A, Wang R, van Leeuwen RW, Klip HG,
de Bock GH, Hollema H, van Criekinge W, de Meyer T, Denil S, van
der Zee AGJ, et al: Discovery of new methylation markers to improve
screening for cervical intraepithelial neoplasia grade 2/3. Clin
Epigenetics. 8:292016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kurdyukov S and Bullock M: DNA methylation
analysis: Choosing the right method. Biology (Basel). 5:E32016.
|
|
68
|
Delaney C, Garg SK and Yung R: Analysis of
DNA methylation by pyrosequencing. Methods Mol Biol. 1343:249–264.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Patiño-Parrado I, Gómez-Jiménez Á,
López-Sánchez N and Frade JM: Strand-specific CpG hemimethylation,
a novel epigenetic modification functional for genomic imprinting.
Nucleic Acids Res. 45:8822–8834. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Qin W, Wolf P, Liu N, Link S, Smets M, La
Mastra F, Forné I, Pichler G, Hörl D, Fellinger K, et al: DNA
methylation requires a DNMT1 ubiquitin interacting motif (UIM) and
histone ubiquitination. Cell Res. 25:911–929. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Grundy SM, Cleeman JI, Daniels SR, Donato
KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith
SC Jr, et al: Diagnosis and management of the metabolic syndrome:
An American Heart Association/National Heart, Lung, and Blood
Institute scientific statement. Circulation. 112:2735–2752. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Expert Panel on Detection, Evaluation
Treatment of High Blood Cholesterol in Adults: Executive summary of
the third report of The National Cholesterol Education Program
(NCEP) expert panel on detection, evaluation, and treatment of high
blood cholesterol in adults (Adult Treatment Panel III). JAMA.
285:2486–2497. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wilson L, Bhatnagar P and Townsend N:
Comparing trends in mortality from cardiovascular disease and
cancer in the United Kingdom, 1983–2013 Joinpoint regression
analysis. Popul Health Metr. 15:232017. View Article : Google Scholar
|
|
74
|
Koene RJ, Prizment AE, Blaes A and Konety
SH: Shared risk factors in cardiovascular disease and cancer.
Circulation. 133:1104–1114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Weir HK, Anderson RN, Coleman King SM,
Soman A, Thompson TD, Hong Y, Moller B and Leadbetter S: Heart
disease and cancer deaths-trends and projections in the United
States 1969–2020. Prev Chronic Dis. 13:E1572016. View Article : Google Scholar
|
|
76
|
Nichols M, Townsend N, Scarborough P and
Rayner M: Trends in age-specific coronary heart disease mortality
in the European Union over three decades: 1980–2009. Eur Heart J.
34:3017–3027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bosetti C, Bertuccio P, Malvezzi M, Levi
F, Chatenoud L, Negri E and La Vecchia C: Cancer mortality in
Europe, 2005–2009 and an overview of trends since 1980. Ann Oncol.
24:2657–2671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Merritt MA, Tzoulaki I, Tworoger SS, De
Vivo I, Hankinson SE, Fernandes J, Tsilidis KK, Weiderpass E,
Tjønneland A, Petersen KE, et al: Investigation of dietary factors
and endometrial cancer risk using a nutrient-wide association study
approach in the EPIC and Nurses’ Health Study (NHS) and NHSII.
Cancer Epidemiol Biomarkers Prev. 24:466–471. 2015. View Article : Google Scholar : PubMed/NCBI
|
